Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT06625320 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Pancreatic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 460 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | December 12, 2025 (Dec 12, 2025) |
As of March 2, 2026: Clinical trial NCT06625320 is currently active_not_recruiting participants. This clinical trial study for pancreatic cancer is not currently accepting new participants at 37 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06625320 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06625320 was last updated Dec 12, 2025 (December 12, 2025). HelloStudys verifies this status automatically.